|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 168.40 SEK | +1.08% |
|
+4.08% | +7.12% |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 4,017 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | 7.12% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 3,827 | 3,787 | 3,729 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | 6.7% | -1.06% | -1.53% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 28.9x | 22.4x | 19.8x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 4.16x | 3.76x | 3.38x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -3.09x | 0.8x | 1.5x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 5.14x | 4.57x | 4.22x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 4.9x | 4.31x | 3.92x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 16.8x | 13.3x | 11.7x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 21.7x | 16.6x | 14.3x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 34.8x | 31.3x | 25.9x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 2.87% | 3.2% | 3.87% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.223 | 3.53 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 1.63% | 1.91% | 2.1% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 5.819 | 7.514 | 8.52 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 47.3% | 42.9% | 41.4% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 781.5 | 878.9 | 952 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 227.5 | 285.8 | 318.4 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 176 | 228.1 | 260.3 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 138.7 | 181.4 | 205.9 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -189.5 | -230 | -288.1 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 168.40 | 168.40 | 168.40 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 2/4/22 | 2/8/23 | 2/7/24 | 2/6/25 | 2/5/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.94x | 4.9x | 16.82x | 1.63% | 406M | |
| 34.27x | 5.99x | 22.93x | 0.27% | 255B | |
| 38.97x | 6.89x | 21.81x | 0.63% | 161B | |
| 45.34x | 12.27x | 27.06x | -.--% | 151B | |
| 16.68x | 3.34x | 10.9x | -.--% | 64.33B | |
| 20.33x | 2.44x | 12.33x | 2.49% | 51.9B | |
| 47.52x | 11.7x | 25.8x | -.--% | 50.25B | |
| 34.83x | 6.84x | 21.72x | -.--% | 49.92B | |
| 33.7x | 6.66x | 22.63x | 0.59% | 48.77B | |
| 76.49x | 7.3x | 22.21x | -.--% | 42.93B | |
| Average | 37.71x | 6.83x | 20.42x | 0.56% | 87.54B | |
| Weighted average by Cap. | 37.75x | 7.31x | 21.96x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
